← back to search

Eric R. Siegel

University of Arkansas Medical Center · US
Area of research
Hematology · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Multiple Myeloma Research and Treatments, Neonatal and fetal brain pathology, Cancer Research and Treatments, and Endometrial and Cervical Cancer Treatments.
h-index
50
citations
9,784
works
417
NIH funding
primary concept
Medicine
email

Recent publications

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix
Proceedings of the National Academy of Sciences 2024cited by 15position: middledoi
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147)
Clinical Cancer Research 2024cited by 8position: middledoi
A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
Cancer 2021cited by 76position: middledoi
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
Annals of Oncology 2021cited by 50position: middledoi
Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis
Clinical Cancer Research 2020cited by 302position: middledoi
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
Blood 2020cited by 70position: middledoi
In Vivo Lymphatic Circulating Tumor Cells and Progression of Metastatic Disease
Cancers 2020cited by 17position: middledoi
In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanoma
Science Translational Medicine 2019cited by 141position: middledoi
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Journal of Clinical Oncology 2018cited by 521position: middledoi
Barriers to Same‐Day Discharge of Patients Undergoing Total and Completion Thyroidectomy
Otolaryngology 2014cited by 41position: middledoi

Grants

Human +
NSF1010507$1,899,9972010–2015PIRePORTER
Virtual Hall of Science (VHOS)
NSF0929206$799,9662009–2013PIRePORTER

Frequent collaborators

Stefania Bellone · Yale University3 papers (2018–2024)Natália Buza · Yale University3 papers (2018–2024)Pei Hui · Yale University3 papers (2018–2024)Alessandro D. Santin · Yale University3 papers (2018–2024)Elena Ratner · Yale Cancer Center3 papers (2018–2024)Peter E. Schwartz · Technische Universität Dresden3 papers (2018–2024)Masoud Azodi · Yale University3 papers (2018–2024)Babak Litkouhi · Stratford University2 papers (2018–2020)Osama Abdelghany · Yale New Haven Hospital2 papers (2018–2020)Nicole Nevadunsky · Albert Einstein College of Medicine2 papers (2018–2020)Amanda N. Fader · University of Milano-Bicocca2 papers (2018–2020)Dana M. Roque · University of Mary2 papers (2018–2020)Dirk Pikaart · Penrose-St. Francis Health Services2 papers (2018–2020)Angeles Alvarez Secord · Duke University2 papers (2018–2020)Paul Celano · American Society of Clinical Oncology2 papers (2018–2020)Ekaterina I. Galanzha · BioVentures (United States)2 papers (2019–2020)Azemat Jamshidi‐Parsian · University of Arkansas for Medical Sciences2 papers (2019–2020)Laura J. Havrilesky · Duke University2 papers (2018–2020)Babak Edraki · John Muir Medical Center2 papers (2018–2020)William J. Lowery · Walter Reed National Military Medical Center2 papers (2018–2020)